These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 22314100)

  • 21. Therapy-induced senescence in cancer.
    Ewald JA; Desotelle JA; Wilding G; Jarrard DF
    J Natl Cancer Inst; 2010 Oct; 102(20):1536-46. PubMed ID: 20858887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular Senescence and Anti-Cancer Therapy.
    You J; Dong R; Ying M; He Q; Cao J; Yang B
    Curr Drug Targets; 2019; 20(7):705-715. PubMed ID: 30556499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The arrival of predictive biomarkers for monitoring therapy response to natural compounds in cancer drug discovery.
    El Bairi K; Atanasov AG; Amrani M; Afqir S
    Biomed Pharmacother; 2019 Jan; 109():2492-2498. PubMed ID: 30551510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular senescence: from anti-cancer weapon to anti-aging target.
    Yuan L; Alexander PB; Wang XF
    Sci China Life Sci; 2020 Mar; 63(3):332-342. PubMed ID: 32060861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Editorial: Therapeutic Modulators of Cellular Senescence: Common Targets in Cancer And Aging.
    Provinciali M; Malavolta M
    Curr Drug Targets; 2016; 17(4):376. PubMed ID: 26882494
    [No Abstract]   [Full Text] [Related]  

  • 26. Network pharmacology of cancer: From understanding of complex interactomes to the design of multi-target specific therapeutics from nature.
    Poornima P; Kumar JD; Zhao Q; Blunder M; Efferth T
    Pharmacol Res; 2016 Sep; 111():290-302. PubMed ID: 27329331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strategies in functional proteomics: Unveiling the pathways to precision oncology.
    Favicchio R; Thepaut C; Zhang H; Arends R; Stebbing J; Giamas G
    Cancer Lett; 2016 Nov; 382(1):86-94. PubMed ID: 26850375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular senescence in gastrointestinal diseases: from pathogenesis to therapeutics.
    Frey N; Venturelli S; Zender L; Bitzer M
    Nat Rev Gastroenterol Hepatol; 2018 Feb; 15(2):81-95. PubMed ID: 29184185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular senescence and cancer chemotherapy resistance.
    Gordon RR; Nelson PS
    Drug Resist Updat; 2012; 15(1-2):123-31. PubMed ID: 22365330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Another facet to the anticancer response to lamellarin D: induction of cellular senescence through inhibition of topoisomerase I and intracellular Ros production.
    Ballot C; Martoriati A; Jendoubi M; Buche S; Formstecher P; Mortier L; Kluza J; Marchetti P
    Mar Drugs; 2014 Jan; 12(2):779-98. PubMed ID: 24473175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of senescence in cancer cells by 5'-Aza-2'-deoxycytidine: Bioinformatics and experimental insights to its targets.
    Putri JF; Widodo N; Sakamoto K; Kaul SC; Wadhwa R
    Comput Biol Chem; 2017 Oct; 70():49-55. PubMed ID: 28802167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unmasking senescence: context-dependent effects of SASP in cancer.
    Faget DV; Ren Q; Stewart SA
    Nat Rev Cancer; 2019 Aug; 19(8):439-453. PubMed ID: 31235879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The importance of predictive biomarkers in oncology drug development.
    Jørgensen JT
    Expert Rev Mol Diagn; 2016 Aug; 16(8):807-9. PubMed ID: 27282189
    [No Abstract]   [Full Text] [Related]  

  • 34. Telomeres and telomerases in cancer.
    Novak KD
    MedGenMed; 2003 Jan; 5(1):21. PubMed ID: 12827082
    [No Abstract]   [Full Text] [Related]  

  • 35. Recent update on discovery and development of Hsp90 inhibitors as senolytic agents.
    Dutta Gupta S; Pan CH
    Int J Biol Macromol; 2020 Oct; 161():1086-1098. PubMed ID: 32561284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. mTOR as a senescence manipulation target: A forked road.
    Saoudaoui S; Bernard M; Cardin GB; Malaquin N; Christopoulos A; Rodier F
    Adv Cancer Res; 2021; 150():335-363. PubMed ID: 33858600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncogenic senescence: a multi-functional perspective.
    Baker DJ; Alimirah F; van Deursen JM; Campisi J; Hildesheim J
    Oncotarget; 2017 Apr; 8(16):27661-27672. PubMed ID: 28416761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial Glutamine Metabolism Determines Senescence Induction After Chemotherapy.
    Kim B; Gwak J; Lee EK; Jeong SM
    Anticancer Res; 2020 Dec; 40(12):6891-6897. PubMed ID: 33288582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is Senescence Reversible?
    Chakradeo S; Elmore LW; Gewirtz DA
    Curr Drug Targets; 2016; 17(4):460-6. PubMed ID: 26302802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of the PML tumor suppressor in drug-induced senescence of human normal and cancer cells by JAK/STAT-mediated signaling.
    Hubackova S; Novakova Z; Krejcikova K; Kosar M; Dobrovolna J; Duskova P; Hanzlikova H; Vancurova M; Barath P; Bartek J; Hodny Z
    Cell Cycle; 2010 Aug; 9(15):3085-99. PubMed ID: 20699642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.